Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Priming with a candidate HIV-1 clade A DNA vaccine followed by boosting with an HIV-1 Clade A MVA vaccine in volunteers at low risk of HIV infection

Go back to Resources

Priming with a candidate HIV-1 clade A DNA vaccine followed by boosting with an HIV-1 Clade A MVA vaccine in volunteers at low risk of HIV infection

Authors:

Location:

Go back to Resources

Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival

Go back to Resources

Pretransplant recipient cytomegalovirus seropositivity and hemodialysis are associated with decreased renal allograft and patient survival

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Predictors of length of stay for pediatric liver transplant recipients

Go back to Resources

Predictors of length of stay for pediatric liver transplant recipients

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience

Go back to Resources

Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS

Go back to Resources

Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics

Go back to Resources

Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics

Authors:

Location:

Go back to Resources

Pediatric transplantation of the kidney, liver and heart: Summary report

Go back to Resources

Pediatric transplantation of the kidney, liver and heart: Summary report

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Ocular risk factors for developing Neovascular AMD in the fellow eyes of patients with unilateral Neovascular AMD

Go back to Resources

Ocular risk factors for developing Neovascular AMD in the fellow eyes of patients with unilateral Neovascular AMD

Authors:

Location:

Go back to Resources

NIH-supported national transplant registry

Go back to Resources

NIH-supported national transplant registry

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

NIH-Supported National Islet Transplantation Registry

Go back to Resources

NIH-Supported National Islet Transplantation Registry

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • Current page 143
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions